Literature DB >> 20117257

Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.

Chiachien J Wang1, I-Ping Chen, Boguslawa Koczon-Jaremko, Adele L Boskey, Yasuyoshi Ueki, Liisa Kuhn, Ernst J Reichenberger.   

Abstract

Cherubism is an autosomal dominant disorder in children characterized by unwarranted symmetrical bone resorption of the jaws with fibrous tissue deposition. Mutations causing cherubism have been identified in the adaptor protein SH3BP2. Knock-in mice with a Pro416Arg mutation in Sh3bp2 exhibit a generalized osteoporotic bone phenotype. In this study, we examined the effects of this "cherubism" mutation on spectroscopic indices of "bone quality" and on osteoblast differentiation. Fourier-transform infrared imaging (FTIRI) analysis of femurs from wild-type and Sh3bp2 knock-in mice showed decreased mineral content, decreased mineral crystallinity/crystal size, and increased collagen maturity in homozygous mutants. To assess osteoblast maturation in vivo, knock-in mice were crossed with transgenic mice over-expressing GFP driven by 3.6-kb or 2.3-kb Col1a1 promoter fragments. Reduced numbers of mature osteoblasts were observed in homozygous mice. Neonatal calvarial cultures, which were enriched for osteoblasts by depletion of hematopoietic cells (negative selection for Ter119- and CD45-positive cells) were investigated for osteoblast-specific gene expression and differentiation, which demonstrated that differentiation and mineralization in homozygous osteoblast cultures was impaired. Co-cultures with calvarial osteoblasts and bone marrow macrophages showed that mutant osteoblasts appear to increase osteoclastogenesis resulting in increased bone resorption on bone chips. In summary, the Sh3bp2 mutation in cherubism mice alters bone quality, reduces osteoblast function, and may contribute to excessive bone resorption by osteoclasts. Our data, together with previous osteoclast studies, demonstrate a critical role of Sh3bp2 in bone remodeling and osteoblast differentiation. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117257      PMCID: PMC2854251          DOI: 10.1016/j.bone.2010.01.380

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  46 in total

1.  Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.

Authors:  Y Ueki; V Tiziani; C Santanna; N Fukai; C Maulik; J Garfinkle; C Ninomiya; C doAmaral; H Peters; M Habal; L Rhee-Morris; J B Doss; S Kreiborg; B R Olsen; E Reichenberger
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

2.  Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation.

Authors:  B Li; S Boast; K de los Santos; I Schieren; M Quiroz; S L Teitelbaum; M M Tondravi; S P Goff
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

3.  Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts.

Authors:  G P Thomas; S U Baker; J A Eisman; E M Gardiner
Journal:  J Endocrinol       Date:  2001-08       Impact factor: 4.286

4.  Col1a1-driven transgenic markers of osteoblast lineage progression.

Authors:  S Dacic; I Kalajzic; D Visnjic; A C Lichtler; D W Rowe
Journal:  J Bone Miner Res       Date:  2001-07       Impact factor: 6.741

5.  Inhibition of osteoblast differentiation by tumor necrosis factor-alpha.

Authors:  L Gilbert; X He; P Farmer; S Boden; M Kozlowski; J Rubin; M S Nanes
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

6.  Spectroscopic characterization of collagen cross-links in bone.

Authors:  E P Paschalis; K Verdelis; S B Doty; A L Boskey; R Mendelsohn; M Yamauchi
Journal:  J Bone Miner Res       Date:  2001-10       Impact factor: 6.741

7.  Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage.

Authors:  I Kalajzic; Z Kalajzic; M Kaliterna; G Gronowicz; S H Clark; A C Lichtler; D Rowe
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

8.  Infrared microscopic imaging of bone: spatial distribution of CO3(2-).

Authors:  H Ou-Yang; E P Paschalis; W E Mayo; A L Boskey; R Mendelsohn
Journal:  J Bone Miner Res       Date:  2001-05       Impact factor: 6.741

9.  Effects of transforming growth factor-beta deficiency on bone development: a Fourier transform-infrared imaging analysis.

Authors:  E Atti; S Gomez; S M Wahl; R Mendelsohn; E Paschalis; A L Boskey
Journal:  Bone       Date:  2002-12       Impact factor: 4.398

10.  In vitro mineralization of fetal rat parietal bones in defined serum-free medium: effect of beta-glycerol phosphate.

Authors:  G Gronowicz; F N Woodiel; M B McCarthy; L G Raisz
Journal:  J Bone Miner Res       Date:  1989-06       Impact factor: 6.741

View more
  9 in total

1.  Fourier transform infrared spectroscopic imaging parameters describing acid phosphate substitution in biologic hydroxyapatite.

Authors:  Lyudmila Spevak; Carol R Flach; Tracey Hunter; Richard Mendelsohn; Adele Boskey
Journal:  Calcif Tissue Int       Date:  2013-02-05       Impact factor: 4.333

2.  Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.

Authors:  Mizuho Kittaka; Kotoe Mayahara; Tomoyuki Mukai; Tetsuya Yoshimoto; Teruhito Yoshitaka; Jeffrey P Gorski; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2017-11-02       Impact factor: 6.741

3.  Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.

Authors:  Teruhito Yoshitaka; Mizuho Kittaka; Shu Ishida; Noriyoshi Mizuno; Tomoyuki Mukai; Yasuyoshi Ueki
Journal:  Bone       Date:  2014-10-31       Impact factor: 4.398

4.  Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.

Authors:  Virginie Prod'Homme; Laurent Boyer; Nicholas Dubois; Aude Mallavialle; Patrick Munro; Xavier Mouska; Isabelle Coste; Robert Rottapel; Sophie Tartare-Deckert; Marcel Deckert
Journal:  J Clin Invest       Date:  2015-02-23       Impact factor: 14.808

5.  Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice.

Authors:  Tomoyuki Mukai; Richard Gallant; Shu Ishida; Mizuho Kittaka; Teruhito Yoshitaka; David A Fox; Yoshitaka Morita; Keiichiro Nishida; Robert Rottapel; Yasuyoshi Ueki
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

Review 6.  The role of SH3BP2 in the pathophysiology of cherubism.

Authors:  Ernst J Reichenberger; Michael A Levine; Bjorn R Olsen; Maria E Papadaki; Steven A Lietman
Journal:  Orphanet J Rare Dis       Date:  2012-05-24       Impact factor: 4.123

7.  SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model.

Authors:  Tomoyuki Mukai; Richard Gallant; Shu Ishida; Teruhito Yoshitaka; Mizuho Kittaka; Keiichiro Nishida; David A Fox; Yoshitaka Morita; Yasuyoshi Ueki
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

8.  Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.

Authors:  Natacha Kadlub; Quentin Sessiecq; Marion Mandavit; Aurore Coulomb L'Hermine; Cecile Badoual; Louise Galmiche; Ariane Berdal; Vianney Descroix; Arnaud Picard; Amélie E Coudert
Journal:  Orphanet J Rare Dis       Date:  2018-09-20       Impact factor: 4.123

Review 9.  Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2.

Authors:  Tomoyuki Mukai; Shunichi Fujita; Yoshitaka Morita
Journal:  Cells       Date:  2019-02-22       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.